Merck halts phase 3 TIGIT trial after immune-mediated adverse events prompt discontinuations 0 13.05.2024 14:48 Fiercebiotech.com Merck halts phase 3 TIGIT trial after immune-mediated adverse events prompt discontinuations jwaldron Mon, 05/13/2024 - 07:48
